The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief examines the U.S. government's efforts in global health security—that is, activities to help countries prepare for and develop capacities to address epidemic and pandemic diseases. It provides history and background, outlines the U.S. agencies carrying out these efforts, describes funding, and highlights key policy issues going forward.
This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.
This policy watch examines global access to COVID-19 vaccines by country income level, assessing country income levels' shares of purchased doses and potential vaccination coverage, while also looking closely at the potential impact of COVAX in addressing vaccine access disparity between high-income and low- and middle-income countries.
Countries are seeking to create a new 'pandemic agreement' at WHO to strengthen pandemic prevention, preparedness, and response. This brief explains what the pandemic agreement is, where the U.S. stands on issues included in the agreement, and potential outcomes of the ongoing negotiations. It also evaluates several criticisms of the agreement and the evidence for each.
This fact sheet examines Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in lower income countries, and explores the role the U.S. government plays in supporting the partnership.
This brief offers an overview of the new multilateral global health financing mechanism known as the Pandemic Fund, which is housed at the World Bank. The brief reviews the evolution of the Fund, its current financial status and donors, U.S. engagement, and policy issues going forward.
This brief reviews the proposed revisions to the World Health Organization-based agreement known as the International Health Regulations (IHR), and the implications for the U.S. WHO member states are expected to adopt the revised IHR at the World Health Assembly meeting this year. The U.S. government has been a leading proponent of many of the expected revisions to the IHR. In this analysis we also evaluate some of the criticisms of the revisions to the IHR.
This Health Policy 101 chapter outlines the U.S. government's historical efforts in global health, which aim to improve health in low- and middle-income countries. While the U.S. has been engaged in international health activities for over a century and has historically been the largest funder and implementer of global health programs worldwide, it is currently undergoing a fundamental shift, with a significantly reduced footprint and role. Key issues addressed include the future direction of U.S. global health leadership, the ability of global health implementers and other donors to continue efforts, and the future role of multilateral institutions in global health.
To help inform ongoing global discussions about the creation of a new financing mechanism for pandemic preparedness and response, including questions about its governance and operations and the extent to which civil society will be formally included, we analyzed 14 major multilateral global health and related institutions to assess how civil society has been engaged in their governance, implementation/programming, and monitoring.
This explainer answers key questions about mpox, the international response to date including the U.S. government’s role, and its challenges. It also discusses how the global emergency might affect the U.S. and the current status of mpox circulation within the U.S.
© 2026 KFF